Psychiatry · Yakima, WA
NPI
1336508423
Since 2016
Specialty
Psychiatry
Code 2084P0800X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
402 S 4th Ave
Yakima, WA, 98902
Phone (509) 575-4084
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
221 services
Medicare patients, 2024
46
Average age 49
Drug cost, 2024
$1.9M
4,711 prescriptions
Company payments, 2025
$202K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew Bogoyas was code 99214 (office e&m - established), 210 times for 44 patients. In total Matthew Bogoyas billed 221 services in 4 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 210 | 44 | $73.41 | $15K |
By year: 2022 $25K for 343 services; 2023 $21K for 286 services; 2024 $17K for 221 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew Bogoyas prescribed most often to Medicare patients was Olanzapine, with 278 prescriptions and refills. In total Matthew Bogoyas wrote 4,711 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Olanzapine Generic | 278 | 298 | 44 | $4,085 |
| Risperidone Generic | 250 | 279 | 43 | $3,851 |
| Quetiapine Fumarate Generic | 232 | 236 | 47 | $2,897 |
| Clonazepam Generic | 218 | 218 | 29 | $2,140 |
| Benztropine Mesylate Generic | 206 | 213 | 43 | $2,393 |
| Sertraline Hcl Generic | 184 | 198 | 36 | $1,941 |
| Trazodone Hcl Generic | 179 | 187 | 47 | $2,378 |
| Prazosin Hcl Generic | 165 | 191 | 35 | $3,029 |
| Aripiprazole Generic | 164 | 178 | 27 | $4,073 |
| Haloperidol Generic | 140 | 140 | 18 | $3,406 |
| Invega Sustenna Paliperidone Palmitate | 140 | 140 | 23 | $460K |
| Divalproex Sodium Er Divalproex Sodium | 111 | 119 | 20 | $6,573 |
| Lamotrigine Generic | 101 | 119 | 31 | $973 |
| Fluoxetine Hcl Generic | 94 | 110 | 17 | $1,110 |
| Clozapine Generic | 91 | 91 | Under 11 | $7,517 |
Brand drugs: - claims; generic drugs: 4,160 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew Bogoyas $202K ($202K in general payments such as food, travel and fees) from 11 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $72K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 86 | $72K |
| Teva Pharmaceuticals USA, Inc. TEVA | 48 | $39K |
| Neurocrine BioSciences, Inc. NBIX | 40 | $37K |
| Axsome Therapeutics, Inc. AXSM | 41 | $32K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 48 | $18K |
| Janssen Scientific Affairs, LLC JNJ | 1 | $2,725 |
| Janssen Pharmaceuticals, Inc JNJ | 7 | $82.79 |
| Alkermes, Inc. ALKS | 3 | $63.57 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $26.1 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $14.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.